Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Exercise of Options

7 Nov 2007 14:06

Phorm Inc07 November 2007 7 November 2007 Phorm, Inc. ("Phorm" or the "Company") Exercise of Options The Company (AIM: PHRM and PHRX) announces that 27,895 share options over commonshares of $0.001 each in the capital of the Company were exercised by employeeson 6 November, 2007. Application has been made for 27,895 common shares to be admitted to trading onAIM. The shares will rank pari passu with existing common shares and it isexpected that admission is expected to occur at 8.00am on 13 November, 2007.Following the issue of these shares the Company will have 12,110,391 votingcommon shares in issue, none of which are in treasury. For Enquiries Phorm, Inc. +44 870 405 7722Kent Ertugrul (Chairman & Chief Executive) Edelman Financial PR +44 20 7344 1325Paul Lockstone +44 7876 685200Sorrel Beynon +44 20 7344 1253 +44 7980 687 255 Canaccord Adams Limited +44 20 7050 6500Nominated AdviserMark WilliamsAndrew Chubb This information is provided by RNS The company news service from the London Stock Exchange

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.